Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    An evidence-based clinical practice guideline for dental pain (surgical and non-surgical)

    This grant funds the creation, distribution, and assessment of evidence-based guidelines for managing dental pain (surgical and non-surgical) to reduce opioid prescriptions.

    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant is no longer accepting proposals

    Food and Drug Administration has archived this opportunity.

    Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

    This grant supports clinical trials and research to improve pain management, addiction treatment, anesthesia safety, and drug prescribing practices.

    HHS-FDA$2,000,000Forecasted

    A Holistic Approach to Study Non-Addictive Natural Products for Pain Management

    This grant supports interdisciplinary research to understand how non-addictive natural products manage chronic pain through holistic, multisystem approaches, aiming to develop safe, evidence-based pain relief strategies.

    HHS-NIH11Forecasted May 25, 2027Forecasted

    Chronic Pain Medicine Research Grant

    The Chronic Pain Medicine Research Grant funds original research from ASRA Pain Medicine members to advance the science, safety, and clinical care of chronic pain.

    ASRADue Feb 1, 2027$75,000

    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

    Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.

    HHS-NIH11Due Dec 16, 2026$350,000

    HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

    NIH supports milestone-driven development of non-addictive small molecule and biologic pain treatments, from lead optimization through Phase I testing, to prepare candidates for Phase II trials.

    HHS-NIH11Due Feb 19, 2027